FDA.reportPublic FDA data

OXALIPLATIN

Substance profile for UNII 04ZR38536J, enriched with FDA NDC listings, DailyMed labels, legacy aliases, and open chemistry identifiers.

Chemical structure for OXALIPLATIN
Structure render from PubChem CID 9887054

Substance Identity#

UNII
04ZR38536J
Preferred term
OXALIPLATIN
Registry number
61825-94-3
Ingredient type
INGREDIENT SUBSTANCE
Molecular formula
C6H14N2.C2O4.Pt
Chemical structure for OXALIPLATIN
Structure render from PubChem CID 9887054

Chemical And Database Identifiers#

InChIKey
ZROHGHOFXNOHSO-BNTLRKBRSA-L
SMILES
[Pt++].[O-]C(=O)C([O-])=O.N[C@@H]1CCCC[C@H]1N
RxCUI
32592
PubChem
9887054
NCIt
C1181
INN ID
6012

Open Chemistry Sources#

Source, Identifier, Link table
SourceIdentifierLink
PubChem Compound9887054pubchem.ncbi.nlm.nih.gov/compound/9887054
PubChem InChIKey SearchZROHGHOFXNOHSO-BNTLRKBRSA-Lpubchem.ncbi.nlm.nih.gov/#query=ZROHGHOFXNOHSO-BNTLRKBRSA-L
RxNorm32592mor.nlm.nih.gov/RxNav/search?searchBy=RXCUI&searchTerm=32592
NCI ThesaurusC1181ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C1181
FDA Substance Registration System04ZR38536Jprecision.fda.gov/uniisearch/srs/unii/04ZR38536J

DailyMed Socrata Ingredients#

Type, DailyMed label, SPL version table
TypeDailyMed labelSPL version
ACTIVE INGREDIENTThese highlights do not include all the information needed to use Oxaliplatin for Injection safely and effectively. See full prescribing information for Oxaliplatin for Injection. OXALIPLATIN FOR INJECTION powder, for solution for intravenous use Initial U.S. Approval: 20025
ACTIVE MOIETYThese highlights do not include all the information needed to use Oxaliplatin for Injection safely and effectively. See full prescribing information for Oxaliplatin for Injection. OXALIPLATIN FOR INJECTION powder, for solution for intravenous use Initial U.S. Approval: 20025
ACTIVE MOIETYOXALIPLATIN INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [HOSPIRA WORLDWIDE, INC.]12
ACTIVE INGREDIENTOXALIPLATIN INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [HOSPIRA WORLDWIDE, INC.]12
ACTIVE MOIETYELOXATIN (OXALIPLATIN) INJECTION, SOLUTION, CONCENTRATE [SANOFI-AVENTIS U.S. LLC]10
ACTIVE INGREDIENTELOXATIN (OXALIPLATIN) INJECTION, SOLUTION, CONCENTRATE [SANOFI-AVENTIS U.S. LLC]10
ACTIVE INGREDIENTOXALIPLATIN INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [ACTAVIS PHARMA, INC.]10
ACTIVE MOIETYOXALIPLATIN INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [ACTAVIS PHARMA, INC.]10
ACTIVE INGREDIENTOXALIPLATIN INJECTION, SOLUTION, CONCENTRATE [FRESENIUS KABI USA, LLC]10
ACTIVE MOIETYOXALIPLATIN INJECTION, SOLUTION, CONCENTRATE [FRESENIUS KABI USA, LLC]10
ACTIVE INGREDIENTOXALIPLATIN INJECTION, SOLUTION, CONCENTRATE [SUN PHARMA GLOBAL FZE]8
ACTIVE MOIETYOXALIPLATIN INJECTION, SOLUTION, CONCENTRATE [SUN PHARMA GLOBAL FZE]8
ACTIVE MOIETYOXALIPLATIN INJECTION, SOLUTION, CONCENTRATE [TEVA PARENTERAL MEDICINES, INC.]6
ACTIVE INGREDIENTOXALIPLATIN INJECTION, SOLUTION, CONCENTRATE [TEVA PARENTERAL MEDICINES, INC.]6
ACTIVE INGREDIENTOXALIPLATIN INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [SUN PHARMA GLOBAL FZE]5
ACTIVE MOIETYOXALIPLATIN INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [SUN PHARMA GLOBAL FZE]5
ACTIVE MOIETYOXALIPLATIN INJECTION, SOLUTION [SANDOZ INC]5
ACTIVE INGREDIENTOXALIPLATIN INJECTION, SOLUTION [SANDOZ INC]5
ACTIVE MOIETYOXALIPLATIN INJECTION, SOLUTION, CONCENTRATE [WINTHROP U.S.]5
ACTIVE INGREDIENTOXALIPLATIN INJECTION, SOLUTION, CONCENTRATE [WINTHROP U.S.]5
ACTIVE MOIETYOXALIPLATIN INJECTION, SOLUTION, CONCENTRATE [HOSPIRA WORLDWIDE, INC.]4
ACTIVE INGREDIENTOXALIPLATIN INJECTION, SOLUTION, CONCENTRATE [HOSPIRA WORLDWIDE, INC.]4
ACTIVE MOIETYOXALIPLATIN INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [SAGENT PHARMACEUTICALS]3
ACTIVE INGREDIENTOXALIPLATIN INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [SAGENT PHARMACEUTICALS]3
ACTIVE MOIETYOXALIPLATIN INJECTION, SOLUTION [SAGENT PHARMACEUTICALS]2
ACTIVE INGREDIENTOXALIPLATIN INJECTION, SOLUTION [SAGENT PHARMACEUTICALS]2
ACTIVE INGREDIENTOXALIPLATIN INJECTION, SOLUTION, CONCENTRATE [WINTHROP U.S.]2
ACTIVE MOIETYOXALIPLATIN INJECTION, SOLUTION, CONCENTRATE [WINTHROP U.S.]2
ACTIVE INGREDIENTOXALIPLATIN INJECTION, SOLUTION, CONCENTRATE OXALIPLATIN INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [HOSPIRA WORLDWIDE, INC.]2
ACTIVE MOIETYOXALIPLATIN INJECTION, SOLUTION, CONCENTRATE OXALIPLATIN INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [HOSPIRA WORLDWIDE, INC.]2
ACTIVE MOIETYOXALIPLATIN POWDER, FOR SOLUTION [PFIZER LABORATORIES DIV PFIZER INC.]2
ACTIVE INGREDIENTOXALIPLATIN POWDER, FOR SOLUTION [PFIZER LABORATORIES DIV PFIZER INC.]2
ACTIVE MOIETYELOXATIN (OXALIPLATIN) INJECTION, SOLUTION, CONCENTRATE [AVENTIS PHARMA LTD.]1
ACTIVE INGREDIENTELOXATIN (OXALIPLATIN) INJECTION, SOLUTION, CONCENTRATE [AVENTIS PHARMA LTD.]1
ACTIVE INGREDIENTOXALIPLATIN FOR INJECTION INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [SUN PHARMA GLOBAL INC.]1
ACTIVE MOIETYOXALIPLATIN FOR INJECTION INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [SUN PHARMA GLOBAL INC.]1
ACTIVE MOIETYOXALIPLATIN INJECTION, SOLUTION [MYLAN INSTITUTIONAL LLC ]1
ACTIVE INGREDIENTOXALIPLATIN INJECTION, SOLUTION [MYLAN INSTITUTIONAL LLC ]1
ACTIVE INGREDIENTOXALIPLATIN INJECTION, SOLUTION [PFIZER LABORATORIES DIV PFIZER INC.]1
ACTIVE MOIETYOXALIPLATIN INJECTION, SOLUTION [PFIZER LABORATORIES DIV PFIZER INC.]1
ACTIVE MOIETYOXALIPLATIN INJECTION, SOLUTION, CONCENTRATE [APP PHARMACEUTICALS, LLC]1
ACTIVE INGREDIENTOXALIPLATIN INJECTION, SOLUTION, CONCENTRATE [APP PHARMACEUTICALS, LLC]1
ACTIVE INGREDIENTOXALIPLATIN POWDER, FOR SOLUTION [MYLAN INSTITUTIONAL LLC ]1
ACTIVE MOIETYOXALIPLATIN POWDER, FOR SOLUTION [MYLAN INSTITUTIONAL LLC ]1